Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹775Cr
Rev Gr TTM
Revenue Growth TTM
29.48%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

SUNSHIEL
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -0.4 | 6.4 | 2.5 | 27.2 | 28.7 | 16.9 | 40.8 | 29.8 | 29.0 | 46.1 | 31.7 | 12.2 |
| 59 | 58 | 57 | 55 | 73 | 70 | 85 | 78 | 99 | 101 | 108 | 86 |
Operating Profit Operating ProfitCr |
| 11.0 | 13.0 | 13.5 | 16.4 | 14.2 | 9.9 | 8.3 | 8.0 | 10.4 | 11.1 | 11.4 | 9.6 |
Other Income Other IncomeCr | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
Depreciation DepreciationCr | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| 5 | 5 | 5 | 7 | 9 | 4 | 4 | 2 | 8 | 9 | 10 | 7 |
| 1 | 2 | 2 | 2 | 3 | 0 | 1 | 1 | 2 | 2 | 2 | 2 |
|
Growth YoY PAT Growth YoY% | 20.1 | 0.5 | -29.3 | 413.0 | 78.8 | 4.4 | -17.8 | -68.2 | -4.2 | 70.1 | 126.7 | 200.0 |
| 5.0 | 5.8 | 5.9 | 7.9 | 7.0 | 5.1 | 3.4 | 1.9 | 5.2 | 6.0 | 5.9 | 5.2 |
| 4.5 | 5.2 | 5.2 | 6.9 | 8.0 | 5.4 | 4.3 | 2.2 | 7.7 | 9.2 | 9.8 | 5.8 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 26.2 | 10.3 | 10.7 | 3.5 | -4.5 | 9.7 | 22.8 | 0.3 | 15.8 | 29.1 | 20.7 |
| 117 | 140 | 159 | 168 | 173 | 164 | 169 | 213 | 214 | 243 | 332 | 394 |
Operating Profit Operating ProfitCr |
| 1.8 | 6.5 | 4.3 | 8.5 | 8.6 | 9.4 | 14.9 | 12.8 | 12.7 | 14.3 | 9.2 | 10.7 |
Other Income Other IncomeCr | 1 | 3 | 0 | 2 | 1 | 0 | 0 | 19 | 2 | 1 | 3 | 4 |
Interest Expense Interest ExpenseCr | 3 | 11 | 9 | 10 | 11 | 10 | 7 | 5 | 7 | 8 | 9 | 7 |
Depreciation DepreciationCr | 3 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 10 | 11 |
| -4 | -3 | -8 | 2 | 0 | 1 | 17 | 39 | 19 | 27 | 18 | 33 |
| -1 | -3 | -1 | 0 | 0 | 1 | 2 | 12 | 5 | 8 | 3 | 8 |
|
| | 73.4 | -689.0 | 118.1 | -81.5 | 189.1 | 2,103.8 | 93.7 | -50.3 | 38.0 | -22.6 | 69.2 |
| -2.7 | -0.6 | -4.0 | 0.7 | 0.1 | 0.4 | 7.1 | 11.3 | 5.6 | 6.7 | 4.0 | 5.6 |
| -4.3 | -1.1 | -8.9 | 1.6 | 0.3 | 0.9 | 19.0 | 36.9 | 18.3 | 25.3 | 19.5 | 32.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| 10 | 9 | 2 | 4 | 4 | 4 | 19 | 46 | 59 | 75 | 88 | 100 |
Current Liabilities Current LiabilitiesCr | 66 | 71 | 83 | 101 | 117 | 84 | 61 | 79 | 63 | 120 | 178 | 143 |
Non Current Liabilities Non Current LiabilitiesCr | 48 | 63 | 48 | 45 | 20 | 51 | 51 | 41 | 48 | 27 | 31 | 28 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 44 | 65 | 59 | 77 | 71 | 72 | 66 | 90 | 93 | 106 | 137 | 111 |
Non Current Assets Non Current AssetsCr | 87 | 86 | 82 | 80 | 76 | 75 | 72 | 83 | 84 | 124 | 167 | 168 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 13 | 1 | 12 | 2 | 15 | 19 | 35 | 33 | 14 | 42 | 48 |
Investing Cash Flow Investing Cash FlowCr | -31 | -17 | -3 | -4 | -2 | -7 | -4 | -17 | -9 | -40 | -50 |
Financing Cash Flow Financing Cash FlowCr | 15 | 18 | -8 | 3 | -30 | -24 | -7 | -9 | -11 | -11 | 2 |
|
Free Cash Flow Free Cash FlowCr | 13 | 1 | 12 | -2 | 12 | 13 | 32 | 17 | 6 | 1 | -2 |
| -404.9 | -80.6 | -174.1 | 177.2 | 6,533.3 | 3,019.8 | 243.8 | 120.0 | 103.3 | 223.2 | 329.0 |
CFO To EBITDA CFO To EBITDA% | 597.5 | 6.9 | 162.3 | 13.8 | 89.5 | 113.8 | 117.1 | 105.5 | 45.3 | 104.0 | 142.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 232 | 241 | 206 | 208 | 119 | 50 | 143 | 455 | 419 | 599 | 501 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 172.9 | 539.2 | 77.0 | 10.1 | 16.6 | 30.7 | 31.8 | 34.4 |
Price To Sales Price To Sales | 1.9 | 1.6 | 1.2 | 1.1 | 0.6 | 0.3 | 0.7 | 1.9 | 1.7 | 2.1 | 1.4 |
Price To Book Price To Book | 13.1 | 14.3 | 20.9 | 18.8 | 10.6 | 4.2 | 5.5 | 8.5 | 6.3 | 7.3 | 5.2 |
| 141.9 | 34.7 | 40.1 | 20.0 | 12.3 | 9.3 | 7.7 | 16.9 | 15.9 | 16.9 | 17.7 |
Profitability Ratios Profitability Ratios |
| 27.5 | 33.0 | 31.5 | 31.4 | 30.5 | 33.0 | 36.3 | 30.6 | 32.1 | 32.0 | 26.0 |
| 1.8 | 6.5 | 4.3 | 8.5 | 8.6 | 9.4 | 14.9 | 12.8 | 12.7 | 14.3 | 9.2 |
| -2.7 | -0.6 | -4.0 | 0.7 | 0.1 | 0.4 | 7.1 | 11.3 | 5.6 | 6.7 | 4.0 |
| -0.5 | 6.3 | 1.5 | 9.6 | 11.5 | 9.2 | 21.1 | 33.3 | 18.5 | 20.6 | 13.8 |
| -18.0 | -5.0 | -67.8 | 10.9 | 2.0 | 5.4 | 54.3 | 51.2 | 20.7 | 22.9 | 15.2 |
| -2.4 | -0.6 | -4.7 | 0.8 | 0.1 | 0.4 | 10.3 | 15.8 | 7.7 | 8.2 | 4.8 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Sunshield Chemicals Limited is a well-established player in the Indian specialty chemicals industry with over **35 years of operational experience**, dating back to its incorporation in **1986** as Sunshield Chemicals Private Limited. The company transitioned to a public limited entity in **1992** and has been listed on the **Bombay Stock Exchange (BSE) since 1995**. In **2021**, a strategic shift occurred when **Indus Petrochem Limited acquired a majority stake**, strengthening its market presence and supply chain capabilities.
The company focuses on manufacturing **low-volume, high-value specialty chemicals**, designed for **performance-driven, application-specific functions** rather than commodity chemical composition. It serves industries such as **Home & Personal Care, Paints & Coatings, Agrochemicals, Lubricants, Plastics, Textiles, and Industrial Formulations**, with a growing footprint in both domestic and international markets.
---
### **Business & Operations**
Sunshield operates a **single integrated manufacturing facility in Raigad, Maharashtra**, supported by on-site storage and a dedicated quality control team. The plant has a total production capacity of **18,076 metric tons per annum** across product lines.
#### **Manufacturing Capabilities**
- Core processes include **alkoxylation (EO/PO), alkylation, sulphation, phosphation, condensation, and formulation**.
- Products are manufactured in multiple physical forms: **noodles, powder, flakes, and liquid**.
- Packaging options range from **25 kg to 1-ton bags** and **200–800 liter drums**, with bulk tanker loads for liquids.
- Key equipment includes reactors, distillators, centrifuges, filters, dryers, and storage tanks.
#### **Recent Expansion & Upgrades**
- Completed capex projects in **2023–2024** to:
- Expand **antioxidant plant capacity**
- Debottleneck and automate the **EO/THEIC unit**
- These upgrades enhance **production efficiency, scalability, and reliability**, supporting increased order fulfillment.
#### **Strategic Infrastructure**
- The **Raigad facility** is strategically located near **National Highway 4** and within **80 km of Jawaharlal Nehru Port Trust (JNPT)** — enabling **efficient logistics** for domestic and export delivery.
- In **2024**, the company began expanding storage capacity by acquiring **14,590 sqm of adjacent land in Village Rasal, Raigad**, from Director Mr. Jeet Malhotra, funded through internal accruals. This supports future scalability in raw material and finished goods storage.
---
### **Product Portfolio**
Sunshield offers a diversified range of performance chemicals across **five major groups**, including:
1. **Surfactants**:
- EO/PO-based **ethoxylates and propoxylates** derived from fatty alcohols, amines, and vegetable oils.
- Used in **detergents, personal care, agrochemicals, paints, and coatings** to improve dispersion and emulsification.
2. **THEIC (Tris 2-Hydroxyethyl Isocyanurate)**:
- Supplied in **powder and noodle form**.
- A **crosslinking agent** used in **wire insulation enamel and PVC heat stabilization**.
- Complex manufacturing process, supported by technical expertise for global and local customers.
3. **HQEE (Hydroquinone Bis(2-hydroxyethyl) Ether)**:
- A **specialty elastomer and crosslinking agent** for high-performance polyurethanes.
- Requires precise technical execution and post-reaction processing.
4. **Antioxidants**:
- Includes **aminic and phenolic antioxidants** in solid and liquid forms.
- Protects polymers and lubricants from **oxidative degradation**.
- Growing demand due to rising use in plastics and industrial applications.
5. **Urea Formaldehyde Resin (UFR)**:
- A **water-insoluble thermosetting resin**, produced via a two-step urea-formaldehyde reaction.
- Used in industrial applications such as **adhesives and coatings**.
---
### **Markets & Customers**
- **Domestic & International Reach**: Serves customers across **India, the Americas, Europe, and the Far East**.
- **Key Clients** include globally recognized companies such as:
- Lubrizol India Pvt. Ltd.
- Asian Paints Ltd.
- Solvay Specialties India
- Elantas Europe
- Products are used in critical applications, including **metal treatment, wire enamels, textiles, cosmetics, tire manufacturing, and agrochemical formulations**.
---
### **Supply Chain & Raw Materials**
- **Primary Raw Materials**: Ethylene Oxide (EO), cyanuric acid, diphenylamine, lauryl alcohol, nonyl phenol, methanol, refined soya oil, and di-isobutylene.
- **Critical Dependency**:
- **Over 35% of ethylene oxide supply** comes from **Reliance Industries Limited (RIL)**.
- The **30+ year partnership** with RIL reflects a stable, long-term supplier relationship.
- **Raw Material Strategy**:
- Increasing **local sourcing** to reduce exposure to global supply chain volatility.
- Maintains **approximately one month’s inventory** of raw materials, WIP, and finished goods to mitigate price fluctuations.
---
### **Innovation & R&D**
- R&D is a **core differentiator**, conducted on-site by a specialized team with expertise in **organic and inorganic chemistry**.
- Collaborations with **IIT Bombay and ICT Mumbai** to drive innovation and new product development.
- Follows a **three-stage scale-up model**: Lab → Prototype → Production, minimizing commercialization risks.
- Focus on developing **eco-friendly, sustainable, and advanced formulations** aligned with regulatory trends and customer demand.
---
### **Competitive Positioning**
- **High industry entry barriers** due to:
- Stringent quality standards
- Lengthy customer approval cycles
- Need for process innovation
- Competes on **product quality, technical expertise, innovation, and customer relationships**, rather than price alone.
- Key domestic competitors include **Galaxy Surfactants, Venus Ethoxylates, and Viswaat Industries**.
- Differentiates through **niche product offerings, in-house R&D, and tailored chemical solutions**.
---
### **Corporate & Strategic Advantages**
- Backed by **Indus Petrochem Limited**, which provides **marketing, distribution expertise, and access to global networks**.
- Strong commitment to **safety and operational excellence** — **35+ years of incident-free operations**.
- Recognized as a **reliable and reputable supplier** of in-house-developed specialty chemicals by leading global and Indian industrial clients.
---